Literature DB >> 26924642

Epigenetics and innate immunity: the 'unTolld' story.

Conor Hennessy1, Declan P McKernan1.   

Abstract

Toll-like receptors (TLRs) are a family of 13 receptors known as pattern-recognition receptors (PRRs) and have a key role in the innate immune response. The TLRs are activated by pathogen-associated molecular patterns (PAMPs) that are structurally conserved molecules present on the surfaces of bacteria and viruses. The activation of these TLRs by pathogens results in the downstream activation of genes involved in the production of proinflammatory factors. There is a lack of understanding on the mechanisms by which TLR gene expression is regulated. Epigenetics could be one such mechanism, which is concerned with changes in gene expression/products that arise without a change in the nucleotide sequence. These changes are brought about by two main mechanisms, DNA methylation and histone modifications. This review seeks to examine the current knowledge regarding the epigenetic regulation of this family of receptors and their signalling pathways.

Mesh:

Substances:

Year:  2016        PMID: 26924642     DOI: 10.1038/icb.2016.24

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  117 in total

Review 1.  Eukaryotic DNA methylation as an evolutionary device.

Authors:  V Colot; J L Rossignol
Journal:  Bioessays       Date:  1999-05       Impact factor: 4.345

2.  Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation.

Authors:  Ihsan Gursel; Mayda Gursel; Hiroshi Yamada; Ken J Ishii; Fumihiko Takeshita; Dennis M Klinman
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

3.  Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis.

Authors:  Kyoko Takahashi; Yutaka Sugi; Akira Hosono; Shuichi Kaminogawa
Journal:  J Immunol       Date:  2009-10-21       Impact factor: 5.422

4.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

5.  Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus.

Authors:  Taís Silveira Assmann; Letícia de Almeida Brondani; Andrea Carla Bauer; Luis Henrique Canani; Daisy Crispim
Journal:  Eur J Endocrinol       Date:  2014-03-08       Impact factor: 6.664

Review 6.  Genetics and pathogenesis of inflammatory bowel disease.

Authors:  Bernard Khor; Agnès Gardet; Ramnik J Xavier
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

Review 7.  Structure and function of mammalian DNA methyltransferases.

Authors:  Renata Zofia Jurkowska; Tomasz Piotr Jurkowski; Albert Jeltsch
Journal:  Chembiochem       Date:  2010-11-29       Impact factor: 3.164

Review 8.  Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders.

Authors:  Katrina J Falkenberg; Ricky W Johnstone
Journal:  Nat Rev Drug Discov       Date:  2014-08-18       Impact factor: 84.694

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.

Authors:  Konrad A Bode; Kate Schroder; David A Hume; Timothy Ravasi; Klaus Heeg; Matthew J Sweet; Alexander H Dalpke
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

View more
  8 in total

1.  LPS promotes HBO1 stability via USP25 to modulate inflammatory gene transcription in THP-1 cells.

Authors:  Chen Long; Yandong Lai; Jin Li; Jiangsheng Huang; Chunbin Zou
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2018-08-04       Impact factor: 4.490

2.  Protective vaccination and blood-stage malaria modify DNA methylation of gene promoters in the liver of Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Foued Ghanjati; Lars Erichsen; Simeon Santourlidis; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2017-03-18       Impact factor: 2.289

Review 3.  Innate immunity to malaria-The role of monocytes.

Authors:  Katherine R Dobbs; Juliet N Crabtree; Arlene E Dent
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

Review 4.  Context-dependent functions of pattern recognition receptors in cancer.

Authors:  Si Ming Man; Brendan J Jenkins
Journal:  Nat Rev Cancer       Date:  2022-03-30       Impact factor: 69.800

5.  Role of epigenetics in modulation of immune response at the junction of host-pathogen interaction and danger molecule signaling.

Authors:  Ana Carolina Morandini; Carlos F Santos; Özlem Yilmaz
Journal:  Pathog Dis       Date:  2016-08-18       Impact factor: 3.166

6.  Epigenetically regulated digital signaling defines epithelial innate immunity at the tissue level.

Authors:  Helen R Clark; Connor McKenney; Nathan M Livingston; Ariel Gershman; Seema Sajjan; Isaac S Chan; Andrew J Ewald; Winston Timp; Bin Wu; Abhyudai Singh; Sergi Regot
Journal:  Nat Commun       Date:  2021-03-23       Impact factor: 17.694

Review 7.  Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations.

Authors:  Gerwyn Morris; Michael Berk; Michael Maes; André F Carvalho; Basant K Puri
Journal:  Mol Neurobiol       Date:  2019-01-26       Impact factor: 5.590

8.  Cleavage-Mediated Regulation of Myd88 Signaling by Inflammasome-Activated Caspase-1.

Authors:  Monika Avbelj; Iva Hafner-Bratkovič; Duško Lainšček; Mateja Manček-Keber; Tina Tinkara Peternelj; Gabriela Panter; Steven P Treon; Boris Gole; Uroš Potočnik; Roman Jerala
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.